Khiron Life Sciences Corp.: Invitation to the Q2 Virtual Investor Summit

Khiron Life Sciences Corp. (TSXV: KHRN) today announced that Alvaro Torres will be attending the Q2 Virtual Investor Summit.

 Event  Q2 Investor Summit
 Date  May 17-18th, 2021
 Presentation  May 18th at 1:15 PM ET
 Location  https://zoom.us/webinar/register/WN_j9QFPydER8qiLMffjsCgFA

 

About Khiron Life Sciences Corp.

Khiron is a vertically integrated medical and CPG cannabis company with core operations in Latin America, and operational activity in Europe and North America. Khiron is the leading medical cannabis provider in Colombia and the first company licensed in Colombia for the cultivation, production, domestic distribution and sales, and international export of both low and high THC medical cannabis products. The Company has filled medical cannabis prescriptions in Colombia, Peru, Germany and the United Kingdom, and is positioned to commence sales in Mexico and Brazil in 2021.

Leveraging wholly-owned medical clinics and proprietary telemedicine platforms, Khiron combines a patient-oriented approach, physician education programs, scientific expertise, product innovation, and agricultural infrastructure to drive prescriptions and brand loyalty. Its Wellbeing unit launched the first branded CBD skincare brand in Colombia, with KuidaTM now marketed in multiple jurisdictions in Latin America, the US and United Kingdom. The Company is led by Co-founder and Chief Executive Officer, Alvaro Torres, together with an experienced and diverse executive team and Board of Directors.

For further information:

Khiron Life Sciences Corp.
Paola Ricardo
4165402970
pricardo@khiron.ca

About the Investor Summit

The Investor Summit (formerly MicroCap Conference) is an exclusive, independent conference dedicated to connecting smallcap and microcap companies with qualified investors. The Q2 Investor Summit will take place virtually, featuring 80+ companies and over 300 institutional and retail investors.

To request complimentary investor registration: please visit our website at www.investorsummitgroup.com

Contact:

Sasha Murray at sasha@investorsummitgroup.com

News Provided by Newsfile via QuoteMedia

The Conversation (0)
Khiron Life Sciences

Khiron Life Sciences

Overview

As a vertically integrated cannabis leader with global growth, Khiron Life Sciences Corp. (TSXV:KHRN,OTCQB:KHRNF,FWB:A2JMZC) targets a market of 620 million people in Latin America. Khiron has operations in Colombia, Uruguay, Chile and a presence in Peru and Mexico.

Khiron has cultivation capabilities in multiple jurisdictions and is engaged in the production, distribution, marketing and export of THC and CBD cannabis. Khiron is leading scientific research, clinical trials and education programs, owns and operates a network of medical clinics that treat 100,000 patients annually, and holds endorsements from the foremost medical associations in the region.

Keep reading...Show less

Discover the evolution of cannabis as Khiron Life Sciences brings its unique medicinal cannabis products to the Latin American, US and global markets.

Latest Press Releases

Related News

×